Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 19 of 19 entries
View as:

Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06267508 Org: User:
Start: 04/30/24 End: 12/31/25 Due: 12/31/26

HIV Point-of-Care Test Evaluation in Infants

Phase: N/A Priority: Normal
NCT ID: NCT02545296 Org: User:
Start: 07/31/15 End: 08/31/17 Due: 08/31/18

Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04874948 Org: User:
Start: 10/08/21 End: 11/09/21 Due: 11/09/22

Identification of Broadly HIV-1 Neutralizing Antibodies (bNAb) in HIV-infected Patients in Mbeya, Tanzania.

Phase: N/A Priority: Normal
NCT ID: NCT03334552 Org: User:
Start: 10/15/17 End: 08/31/24 Due: 08/31/25

A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01714414 Org: User:
Start: 12/31/12 End: 02/28/17 Due: 02/28/18

PanACEA Sutezolid Dose-finding and Combination Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT03959566 Org: User:
Start: 05/06/21 End: 09/30/22 Due: 09/30/23

A Single Ascending Dose Study of BTZ043

Phase: N/A Priority: Normal
NCT ID: NCT03590600 Org: User:
Start: 06/07/18 End: 03/05/19 Due: 03/05/20

Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB)

Phase: N/A Priority: Normal
NCT ID: NCT03734172 Org: User:
Start: 01/21/19 End: 12/31/22 Due: 12/31/23

TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate

Phase: N/A Priority: Normal
NCT ID: NCT06513286 Org: User:
Start: 05/31/25 End: 12/31/26 Due: 12/31/27

A Blinded, Cross-sectional, Diagnostic Evaluation Study Performed in Pulmonary TB Suspects at the TB Dispensary for Sector 4 of the Marius-Nasta-Institute in Bucharest, Romania

Phase: N/A Priority: Normal
NCT ID: NCT02382107 Org: User:
Start: 03/31/15 End: 08/31/17 Due: 08/31/18

Early Risk Assessment in Household Contacts (≥10 Years) of TB Patients by New Diagnostic Tests in 3 African Countries

Phase: N/A Priority: Normal
NCT ID: NCT04781257 Org: User:
Start: 03/01/21 End: 04/30/24 Due: 04/30/25

Establishment of a Clinical Trial Unit in Mavalane, Maputo, in Mozambique

Phase: N/A Priority: Normal
NCT ID: NCT02156882 Org: User:
Start: 06/30/14 End: 09/30/16 Due: 09/30/17

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)

Phase: N/A Priority: Normal
NCT ID: NCT04044001 Org: User:
Start: 11/15/19 End: 05/31/22 Due: 05/31/23

BTZ-043 Dose Evaluation in Combination and Selection

Phase: N/A Priority: Normal
NCT ID: NCT05926466 Org: User:
Start: 09/21/23 End: 08/31/24 Due: 08/31/25

PanACEA - STEP2C -01

Phase: N/A Priority: Normal
NCT ID: NCT05807399 Org: User:
Start: 04/14/23 End: 02/23/25 Due: 02/23/26

Early Bactericidal Activity (EBA) of SQ109 in Adult Subjects With Pulmonary TB

Phase: N/A Priority: Normal
NCT ID: NCT01218217 Org: User:
Start: 11/30/10 End: 05/31/12 Due: 05/31/13

Neonatal HIV Early Infant Diagnosis (EID) Versus Standard of Care EID- Long Term Impact on inFant hEalth (LIFE)

Phase: N/A Priority: Normal
NCT ID: NCT04032522 Org: User:
Start: 10/23/19 End: 01/01/23 Due: 01/01/24

Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design

Phase: N/A Priority: Normal
NCT ID: NCT01785186 Org: User:
Start: 04/30/13 End: 03/31/15 Due: 03/31/16

SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia

Phase: N/A Priority: Normal
NCT ID: NCT06435403 Org: User:
Start: 11/10/22 End: 02/28/25 Due: 02/28/26